|
rdfs:label
|
"Ketorolac"@de
"Ketorolac"@id
"Ketorolac"@it
"Ketorolac"@ro
"Ketorolac"@vi
"Ketorolaco"@es
"Ketorolak"@bs
"Ketorolak"@sh
"Ketorolak"@sr
"Ketorolak"@sv
"Ketorolak"@tr
"Ketorolako"@eu
"cetorolaco de trometamina"@pt
"ketorolaakki"@fi
"ketorolac"@en
"ketorolac"@nl
"ketorolac"@gpe
"ketorolak"@cs
"ketorolak"@pl
"ketorolak"@sl
"kétorolac"@fr
"кеторолак"@ru
"кеторолак"@uk
"Կետորոլակ"@hy
"كيتورولاك"@ar
"كيتورولاك"@azb
"کتورولاک"@fa
"কিটোরোলাক"@bn
"କେଟୋରୋଲାକ"@or
"కేటోరోలాక్"@te
"คีโตโรแลค"@th
"ケトロラク"@ja
"克多炎"@zh
"케토롤락"@ko
|
|
skos:altLabel
|
"(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid"@gpe
"(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid"@en
"(+-)-Ketorolac"@gpe
"(+-)-Ketorolac"@en
"66635-83-4"@fr
"74103-06-3"@fr
"Acular"@it
"Acular"@gpe
"Acular"@en
"C15H13N1O3"@it
"C15H13NO3"@sl
"C15H13NO3"@fi
"C15H13NO3"@fr
"Cetorolaco"@pt
"Dolac"@es
"Ketorolac"@gpe
"Ketorolac"@en
"Ketorolac"@fr
"Ketorolac trometamina"@it
"Ketorolac trometamina"@ro
"Ketorolac trometamină"@ro
"Ketorolaco"@gpe
"Ketorolaco"@en
"Ketorolacum"@gpe
"Ketorolacum"@en
"Kétorolac"@gpe
"Kétorolac"@en
"Lixidol"@it
"Toradol"@it
"Toradol"@sv
"Toradol"@gpe
"Toradol"@en
"rac-Ketorolac"@gpe
"rac-Ketorolac"@en
"Акьюлар"@ru
"Ваторлак"@ru
"Долак"@ru
"Доломин"@ru
"Кетадроп"@ru
"Кетанов"@ru
"Кеторол"@ru
"Матролгин"@ru
"Торадол"@ru
"ケトロラック"@ja
|
|
schema:description
|
"antiinflamatorio no esteroideo"@es
"cheemesch Verbindung"@lb
"cheemsch Verbinnen"@nds
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"compuesto quimico"@an
"compuestu químicu"@ast
"compus chimic"@ro
"farmaco"@it
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kemična spojina; nesteroidna protivnetna učinkovina"@sl
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"läkemedel"@sv
"médicament"@fr
"nonsteroidal anti-inflammatory drug"@gpe
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"лекарственное средство, НПВП"@ru
"хемиско соединение"@mk
"хімічна сполука"@uk
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"یکی از داروهای ضدالتهاب غیراستروئیدی"@fa
"রাসায়নিক যৌগ"@bn
"କେଟୋରୋଲାକ ହେଉଛି ଏକ ନନଷ୍ଟେରଏଡାଲ୍ ଆଣ୍ଟି-ଇନ୍ଫ୍ଲାମେଟୋରୀ ଔଷଧ (NSAID) ଯାହା ଯନ୍ତ୍ରଣା ନିବାରଣ ନିମନ୍ତେ ବ୍ୟବହୃତ ହୁଏ ।"@or
"രാസസംയുക്തം"@ml
"비스테로이드 소염제"@ko
|
|
schema:dateModified
|
"2026-10-19T16:05:26+00:00"^^xsd:dateTime
|
|
schema:version
|
2558840073
|
|
wikibase:identifiers
|
52
|
|
wikibase:sitelinks
|
30
|
|
wikibase:statements
|
82
|
|
p:P10245
|
wd:statement/Q2014797-2b99988f-49a1-77fd-cb72-a65716649eef
|
|
wd:statement/Q2014797-5e6750bd-4df6-4ffc-30aa-6721f22919f1
|
|
wd:statement/Q2014797-7e41ea17-4686-6dc7-fc8a-bd543296f17f
|
|
wd:statement/Q2014797-e85bda35-41a7-bf2f-06c1-3059cc207756
|
|
p:P10283
|
wd:statement/Q2014797-02688DDE-1463-4D98-9D43-365B310F7F03
|
|
wd:statement/Q2014797-A9C19CA6-61BC-4761-8D1A-774A9EEC2DD2
|
|
p:P11089
|
wd:statement/Q2014797-F73E5612-FC62-443C-AB39-591F774B88BD
|
|
p:P11143
|
wd:statement/Q2014797-F37E0002-7198-4717-B8C1-808E19BFB976
|
|
p:P11198
|
wd:statement/Q2014797-8F2485B1-04B8-4D64-9B6C-A077C6BDE6BE
|
|
p:P11199
|
wd:statement/Q2014797-BCAABAA7-AF96-4D23-8512-9CE450FE0DBB
|
|
p:P117
|
wd:statement/Q2014797-be7b28e1-4429-ba46-d1e9-9bf3a2c77f15
|
|
p:P129
|
wd:statement/Q2014797-0F3CBF39-9B41-458A-95A2-5D18A69775B4
|
|
wd:statement/Q2014797-45EB8C61-1030-447D-851E-48934EFD7849
|
|
wd:statement/Q2014797-7158A2D0-F9B0-4358-8D34-FCA783EF6D53
|
|
wd:statement/Q2014797-A2D8E55D-AA60-49F3-AB8C-6D816EE40AC8
|
|
p:P1987
|
wd:statement/Q2014797-C897CA29-E228-4AAB-935A-916D69383C52
|
|
p:P2057
|
wd:statement/Q2014797-6CE1AED7-B94E-41F1-95F2-BCE9DA3FBBBA
|
|
p:P2067
|
wd:statement/Q2014797-0C320DEB-F9B3-45F0-839B-0743CA3AB975
|
|
p:P2115
|
wd:statement/Q2014797-12766223-12F1-4002-BCE1-E5993A56AB02
|
|
p:P2175
|
wd:statement/Q2014797-10C8218E-13AC-4C2F-8EF1-A8C75B64B736
|
|
p:P231
|
wd:statement/Q2014797-156A8DE1-60A0-4D30-87A2-4C95B9D539F5
|
|
p:P232
|
wd:statement/Q2014797-d5a1ff8a-402d-06d3-81ae-64ebb2cd9824
|
|
p:P233
|
wd:statement/Q2014797-C93FD0E7-59A7-4373-979E-B6A5AC2EB753
|
|
p:P234
|
wd:statement/Q2014797-4C6CE61E-8814-49DB-98F8-26D7CF5E3CD5
|
|
p:P235
|
wd:statement/Q2014797-26DAFAE7-FA17-44FD-B701-481691FA77D4
|
|
p:P2566
|
wd:statement/Q2014797-f36e11ae-46e2-ad14-3358-50ad2c9bcb93
|
|
p:P267
|
wd:statement/Q2014797-A3BCAAAC-0BF8-429A-A76D-A1E813944E2F
|
|
wd:statement/Q2014797-D852A07B-924D-47D7-B801-8550C5466C1A
|
|
p:P274
|
wd:statement/Q2014797-4192029F-24A0-4934-8862-ECF588906C0A
|
|
p:P279
|
wd:statement/Q2014797-CCA363A6-63B4-4366-8273-00E695C08794
|
|
p:P2868
|
wd:statement/Q2014797-53D5BB61-1652-4E7C-9D9F-459F9FCE1873
|
|
wd:statement/Q2014797-D5EE77BB-0A40-4094-B7C1-39ADA25A9706
|
|
p:P2877
|
wd:statement/Q2014797-A6BB5D02-7AF1-42B5-AFD3-C6BE91A7F193
|
|
p:P2892
|
wd:statement/Q2014797-32B38713-6C9B-44F0-995F-1B1A33002EF1
|
|
p:P31
|
wd:statement/Q2014797-BF7339E3-A1F6-4F60-BDA0-907234839D2C
|
|
p:P3117
|
wd:statement/Q2014797-8750F2FA-01E1-4F33-9956-DE1EF88CC38B
|
|
p:P3345
|
wd:statement/Q2014797-DC352DC5-513F-4B4B-927A-2DDD6B81815F
|
|
p:P3489
|
wd:statement/Q2014797-108C1BFE-0EA5-4B39-8AE0-932E7E5BA920
|
|
wd:statement/Q2014797-FD05B541-979F-4CD1-A03C-44B5E240F92C
|
|
p:P366
|
wd:statement/Q2014797-3CC59C23-8742-45E3-AE0F-815EE8397674
|
|
p:P373
|
wd:statement/Q2014797-bce22086-4254-3717-5ead-f1388ad8f38d
|
|
p:P3780
|
wd:statement/Q2014797-207EB07D-F039-48C8-935E-A4710968CBBC
|
|
wd:statement/Q2014797-64B76712-B954-4211-9A25-CE388F77610A
|
|
wd:statement/Q2014797-75DED94A-815D-4D60-99A2-683ECF049DF0
|
|
p:P4168
|
wd:statement/Q2014797-477ED17F-6F44-4530-BC77-6BC1AAD7E656
|
|
p:P4235
|
wd:statement/Q2014797-1C8E3AA1-B389-4178-A711-A335D4DB112C
|
|
p:P4250
|
wd:statement/Q2014797-42E4FC61-5FAA-414B-8C67-79099676F216
|
|
wd:statement/Q2014797-A3E0FEEE-C9B4-40FF-AC51-EF1745ED3BF5
|
|
p:P486
|
wd:statement/Q2014797-5371E2B9-AA3F-48E3-862B-A54ACAFC8522
|
|
p:P4964
|
wd:statement/Q2014797-146FE485-A3E1-4C42-A413-0AABE6FA298D
|
|
wd:statement/Q2014797-6276E8DA-03E5-4AC6-A4C8-05C5329E1790
|
|
wd:statement/Q2014797-9CF82F52-5E0A-47A2-B712-B01579DF2C4C
|
|
wd:statement/Q2014797-CB9EF1F0-2511-4CCA-8F1D-B05A84EB188A
|
|
p:P527
|
wd:statement/Q2014797-4C9BE38F-3218-4EB8-98E6-26358332A25B
|
|
wd:statement/Q2014797-A238B8B6-DC33-4136-88D5-120A794F134A
|
|
wd:statement/Q2014797-B164FC70-886C-43D0-9EF1-61DB782CC727
|
|
p:P592
|
wd:statement/Q2014797-C89DD1C5-6211-4890-9847-25A672E3C973
|
|
p:P595
|
wd:statement/Q2014797-C9D294E5-1555-4D00-A8F1-BD371DC6D8FD
|
|
p:P636
|
wd:statement/Q2014797-638a2117-46f6-a27d-c375-16ea3e20e0f4
|
|
wd:statement/Q2014797-d8517ff5-4b0b-c4d4-8072-fd17edf36df6
|
|
wd:statement/Q2014797-dfede9eb-4df5-e0d6-9303-bac91b1076a9
|
|
p:P6366
|
wd:statement/Q2014797-8CF74C50-8786-4903-BD27-E1230386A016
|
|
p:P646
|
wd:statement/Q2014797-A6BBF176-B7DC-4D5A-865D-AD8B752BC936
|
|
p:P652
|
wd:statement/Q2014797-33C5046A-7AFA-4A3E-AA65-2C6FBB4F124B
|
|
p:P661
|
wd:statement/Q2014797-5B812C7E-2BD3-441F-8054-2904A8A4B621
|
|
p:P662
|
wd:statement/Q2014797-B5DB6081-4974-45BD-B2F3-ADB70A0FEF30
|
|
p:P665
|
wd:statement/Q2014797-73A7250D-F9EF-4F6A-90D4-6412AA192FA2
|
|
p:P6689
|
wd:statement/Q2014797-2A8A6B0D-A8D4-4297-B1D3-4460DF5A51B8
|
|
wd:statement/Q2014797-609DD8F1-42EC-484B-8DBF-6DBB0EAAEA75
|
|
wd:statement/Q2014797-6DD763FB-F19F-4335-963C-71A3D0580023
|
|
wd:statement/Q2014797-C9C797F2-4229-4D59-B0E7-8E9121F008C7
|
|
wd:statement/Q2014797-F17750B5-906E-4395-B668-C6CB9391072A
|
|
p:P672
|
wd:statement/Q2014797-dd98990e-443d-43fe-efb7-6fb5b220e68d
|
|
p:P683
|
wd:statement/Q2014797-0789f327-43ab-cf0f-90cf-a2e3c5eb5302
|
|
wd:statement/Q2014797-B2366B15-F3CF-44A2-B707-C56815CD0E1B
|
|
p:P715
|
wd:statement/Q2014797-17997F28-531E-4248-ABBD-9F4D495C1505
|
|
p:P7830
|
wd:statement/Q2014797-3EFC2C40-91C3-4F06-9DCF-0E1F1DAD71E2
|
|
p:P8026
|
wd:statement/Q2014797-CD00C70D-70E1-42AF-B131-93F7433EA99A
|
|
p:P8408
|
wd:statement/Q2014797-8EB3C8FA-3DA5-44F0-9E78-F10834DD50C9
|
|
p:P8494
|
wd:statement/Q2014797-9F67EFBE-4C5E-4985-B88B-4F780AEB287C
|
|
p:P8814
|
wd:statement/Q2014797-59F2412E-4A5D-4376-A423-D91FCD1DF629
|
|
p:P9272
|
wd:statement/Q2014797-B4FF06C5-3090-4DBB-889A-EBA7A2C30C57
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000178380>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/D020910>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL469>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2778446825>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/3694>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3826>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/C07062>
|
|
p:direct-normalized/P672
|
<http://id.nlm.nih.gov/mesh/D03.633.100.473.420.485>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_6129>
|
|
<http://purl.obolibrary.org/obo/CHEBI_76223>
|
|
p:direct-normalized/P8408
|
<http://kbpedia.org/kko/rc/Ketorolac>
|
|
p:direct-normalized/P8814
|
<http://wordnet-rdf.princeton.edu/rdf/id/03617587-n>
|
|
wdt:P10245
|
"a601241"
|
|
"a611042"
|
|
"a614011"
|
|
"a693001"
|
|
wdt:P10283
|
"C2778446825"
|
|
"C2909274023"
|
|
wdt:P11089
|
"584497"
|
|
wdt:P11143
|
"Ketorolac"
|
|
wdt:P11198
|
"1529"
|
|
wdt:P11199
|
"PD010012"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Ketorolac.svg>
|
|
wdt:P129
|
Prostaglandin-endoperoxide synthase 1
|
|
Prostaglandin-endoperoxide synthase 2
|
|
wdt:P1987
|
"2933.99.47"
|
|
wdt:P2057
|
"HMDB0014608"
|
|
wdt:P2067
|
255.089543^^xsd:decimal
|
|
wdt:P2115
|
"N0000178380"
|
|
wdt:P2175
|
migraine
|
|
wdt:P231
|
"74103-06-3"
|
|
wdt:P232
|
"616-049-1"
|
|
wdt:P233
|
"C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O"
|
|
wdt:P234
|
"InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)"
|
|
wdt:P235
|
"OZWKMVRBQXNZKK-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.110.314"
|
|
wdt:P267
|
"M01AB15"
|
|
"S01BC05"
|
|
wdt:P274
|
"C₁₅H₁₃NO₃"
|
|
wdt:P279
|
non-steroidal anti-inflammatory drug
|
|
wdt:P2868
|
non-steroidal anti-inflammatory drug
|
|
cyclooxygenase inhibitors
|
|
wdt:P2877
|
"14891"
|
|
wdt:P2892
|
"C0073631"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID8023189"
|
|
wdt:P3345
|
"35827"
|
|
wdt:P3489
|
US pregnancy category C
|
|
Australian pregnancy category C
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Ketorolac"
|
|
wdt:P3780
|
Acular
|
|
Sprix
|
|
Acuvail
|
|
wdt:P4168
|
"613435"
|
|
wdt:P4235
|
"ketorolac"
|
|
wdt:P4250
|
30.0^^xsd:decimal
|
|
wdt:P486
|
"D020910"
|
|
wdt:P4964
|
"splash10-004i-9200000000-238f6cde2fac6b0ba421"
|
|
"splash10-056r-9500000000-a993ea029f81823db36e"
|
|
"splash10-0a4i-0900000000-49260d5fd66684718972"
|
|
"splash10-0a4i-3900000000-cf3a2eedecd98f879db6"
|
|
wdt:P527
|
carbon
|
|
nitrogen
|
|
oxygen
|
|
wdt:P592
|
"CHEMBL469"
|
|
wdt:P595
|
"6661"
|
|
wdt:P636
|
oral administration
|
|
intramuscular injection
|
|
intravenous infusion and defusion
|
|
wdt:P6366
|
"2778446825"
|
|
wdt:P646
|
"/m/05l5j6"
|
|
wdt:P652
|
"YZI5105V0L"
|
|
wdt:P661
|
"3694"
|
|
wdt:P662
|
"3826"
|
|
wdt:P665
|
"C07062"
|
|
wdt:P6689
|
"MSBNK-Univ_Connecticut-CO000241"
|
|
"MSBNK-Univ_Connecticut-CO000242"
|
|
"MSBNK-Univ_Connecticut-CO000243"
|
|
"MSBNK-Univ_Connecticut-CO000244"
|
|
"MSBNK-Univ_Connecticut-CO000245"
|
|
wdt:P672
|
"D03.633.100.473.420.485"
|
|
wdt:P683
|
"6129"
|
|
"76223"
|
|
wdt:P715
|
"DB00465"
|
|
wdt:P7830
|
"Ketorolac"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E*
|
|
wdt:P8408
|
"Ketorolac"
|
|
wdt:P8494
|
"DTXCID503189"
|
|
wdt:P8814
|
"03617587-n"
|
|
wdt:P9272
|
"34399"
|